Emerging Healthcare Solutions, Inc.: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

HOUSTON--(BUSINESS WIRE)--Emerging Healthcare Solutions, Inc. (PinkSheets:EHSI) announced today that its newly acquired biotechnology division Celulas Genetica seeks to contract a Chinese firm to test a new stem-cell treatment for liver disease.